Vilin Bio Med

Vilin Bio Med FCF Yield

The Free Cash Flow Yield of Vilin Bio Med (VILINBIO.NS) as of Nov 3, 2026 is 0.43 %. In the previous year, Free Cash Flow Yield was -2.04 % — a change of -120.82% (higher).

FCF Yield

0.43 %

YoY

-120.82%

Last updated:

Free Cash Flow Yield of Vilin Bio Med is 2022 0.43 % . Free Cash Flow Yield of Vilin Bio Med was 2021 -2.04 % . It decreases by -120.82% higher compared to the previous year.

The Vilin Bio Med FCF Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Yield
Date
FCF Yield
Jan 1, 2020
-3.02 INR
Jan 1, 2021
-2.04 INR
Jan 1, 2022
0.43 INR
The Vilin Bio Med FCF Yield history
YEARFCF YieldYoY
0.43 %-120.82%
-2.04 %-32.31%
-3.02 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Vilin Bio Med Stock analysis

What does Vilin Bio Med do? Vilin Bio Med Ltd manufactures pharmaceutical products including solid oral dosage forms such as Cefixime, Azithromycin, and Sulmtmicilline, along with oral liquids, external preparations, and dry powders. The company's beta-lactam products treat bacterial infections, while non-beta-lactam products address conditions like colds, flu, fever, and antimalarial needs. Its external preparations include ointments, creams, lotions, gels, and pates for skin applications. The firm focuses on domestic manufacturing within India, serving the local market with a diverse product portfolio. The company's product categories target various medical conditions, with beta-lactam medicines specifically for bacterial infections and non-beta-lactam products for general ailments. Its external preparations cater to topical skin treatments, offering formulations like ointments and creams. Vilin Bio Med Ltd operates as a domestic manufacturer, producing pharmaceuticals for the Indian market without international expansion mentioned in the description. Vilin Bio Med Ltd's product range includes specific medications such as Aceclofenac, Citicolin Sodium, Metformine, Pregabaline, Gabapentin, Diclofenac Sodium, Thiocolchicoside, Linseed Oil, Menthol, and Methyl Salcilate, which support its positioning in the pharmaceutical sector. The company's focus on domestic manufacturing ensures its products are tailored to local healthcare needs, with no indication of export activities or international partnerships. Vilin Bio Med is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vilin Bio Med stock

Free Cash Flow Yield of Vilin Bio Med is 0.43 % in 2022.

Free Cash Flow Yield of Vilin Bio Med changed from -2.04 % to 0.43 %, representing a -120.82% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Yield Vilin Bio Med since 2006 – with annual values, charts, and detailed analysis.

FCF Yield measures the free cash flow per share relative to the stock price. It indicates how much cash a company generates for each dollar invested.

To evaluate Free Cash Flow Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Yield's Vilin Bio Med with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Vilin Bio Med

All Key Metrics — Vilin Bio Med